Skip to main content
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

GoodRx Holdings, Inc. - Class A Common Stock (NQ:GDRX)

4.020 UNCHANGED
Streaming Delayed Price Updated: 4:00 PM EDT, Oct 15, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about GoodRx Holdings, Inc. - Class A Common Stock

< Previous 1 2
...
13 14 15 16 17 18 19 20 Next >
New Report from GoodRx Shows Positive Impact of Giving Pharmacists the Power to Prescribe
From GoodRx
Via Business Wire
GoodRx to Present at Upcoming Investor Conferences
From GoodRx Holdings, Inc.
Via Business Wire
Should You Buy the Nasdaq's 4 Worst-Performing Stocks of 2022?
These four tech stocks are down nearly 90%. 
Via The Motley Fool
Before Pushing Others At Work, Take A Look In The Mirror
Leaders often see their job as driving greatness from others. But the first step is developing your own leadership style. 
Via Investor's Business Daily
Expert Ratings for GoodRx Holdings
GoodRx Holdings (NASDAQ:GDRX) has observed the following analyst ratings within the last quarter: 
Via Benzinga
What 13 Analyst Ratings Have To Say About GoodRx Holdings
  GoodRx Holdings (NASDAQ:GDRX) has observed the following analyst ratings within the last quarter: 
Via Benzinga
GoodRx Holdings: Q2 Earnings Insights
  GoodRx Holdings (NASDAQ:GDRX) reported its Q2 earnings results on Monday, August 8, 2022 at 04:07 PM. Here's what investors need to know about the announcement. 
Via Benzinga
GoodRx Announces Provider Mode, An Innovative Experience Built Specifically for Healthcare Providers
From GoodRx
Via Business Wire
GoodRx and Biogen Collaborate to Help Enhance Enrollment Experience for Providers Who Have Chosen to Start Multiple Sclerosis Patients on VUMERITY®
From GoodRx
Via Business Wire
GoodRx Announces Date for Third Quarter 2022 Earnings Release and Conference Call
From GoodRx Holdings Inc.
Via Business Wire
Alphabet To $134? Plus This Analyst Slashes Price Target On McDonald's
Credit Suisse cut the price target on Alphabet Inc. (NASDAQ: GOOGL) from $140 to $134. Credit Suisse analyst Stephen Ju maintained an Outperform rating on the stock. Alphabet shares fell 1.2% to $96.69... 
Via Benzinga
Where GoodRx Holdings Stands With Analysts
Over the past 3 months, 11 analysts have published their opinion on GoodRx Holdings (NASDAQ:GDRX) stock. These analysts are typically employed by large Wall Street banks and tasked with understanding a... 
Via Benzinga
GoodRx Offers Free Telehealth Appointments to Florida Residents Affected by Hurricane Ian
From GoodRx
Via Business Wire
Benzinga's Top Ratings Upgrades, Downgrades For September 16, 2022
  
Via Benzinga
What 14 Analyst Ratings Have To Say About GoodRx Holdings
Over the past 3 months, 14 analysts have published their opinion on GoodRx Holdings (NASDAQ:GDRX) stock. These analysts are typically employed by large Wall Street banks and tasked with understanding a... 
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For September 7, 2022
Upgrades 
Via Benzinga
GoodRx to Present at the Goldman Sachs Communacopia + Technology Conference
From GoodRx Holdings, Inc.
Via Business Wire
Looking Into GoodRx Holdings's Return On Capital Employed
GoodRx Holdings (NASDAQ:GDRX) brought in sales totaling $191.80 million during Q2 according to data provided by Benzinga Pro. However, earnings decreased 111.51%, resulting in a loss of $1.42 million. 
Via Benzinga
This Healthcare Stock Dipped Over 30%; Here Are 83 Biggest Movers From Yesterday
Gainers 
Via Benzinga
GoodRx Holdings, Inc. (NASDAQ: GDRX) Investor Alert: Investigation over Potential Wrongdoing
San Diego, CA -- (SBWIRE) -- 08/15/2022 -- An investigation was announced over potential breaches of fiduciary duties by certain directors at GoodRx Holdings, Inc. 
Via SBWire
The Most Expensive Drug From Novartis Associated With Two Deaths: Report
Two children with spinal muscular atrophy have died after receiving Novartis AG's (NYSE: NVS) Zolgensma, a one-time gene therapy, spotlighting its risks and questioning the safety of genetic medicines... 
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For August 12, 2022
  
Via Benzinga
WeTrade, Roblox And Some Other Big Stocks Moving Lower On Wednesday
  OptimizeRx Corporation (NASDAQ: OPRX) shares fell 26.7% to $16.32 after the company reported worse-than-expected Q2 EPS and sales results and issued FY22 sales guidance below estimates. 
Via Benzinga
Why Verona Pharma Is Trading Higher By Around 84%, Here Are 85 Stocks Moving In Tuesday's Mid-Day Session
Gainers Verona Pharma plc (NASDAQ: VRNA) shares jumped 83.6% to $12.70 after the company announced ensifentrine met its primary endpoint and secondary endpoints in the Phase 3 ENHANCE-2 trial for COPD.... 
Via Benzinga
Qualys, ShockWave Medical, News Corporation And Some Other Big Stocks Moving Higher On Tuesday
  Verona Pharma plc (NASDAQ: VRNA) shares jumped 83.6% to $12.70 after the company announced ensifentrine met its primary endpoint and secondary endpoints in the Phase 3 ENHANCE-2 trial for COPD. The... 
Via Benzinga
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
  
Via Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday
We're starting off Tuesday with a breakdown of the biggest pre-market stock movers traders will want to keep an eye on today! 
Via InvestorPlace
Why Is BIMI International Medical Higher By Around 70%: Here Are 38 Stocks Moving Premarket
Gainers BIMI International Medical Inc. (NASDAQ: BIMI) shares rose 69.6% to $1.04 in pre-market trading after Fnu Oudom reported a stake of 44% in the company in 13D. 
Via Benzinga
GameStop, Signify Health And Some Other Big Gainers From Monday
U.S. stocks closed mixed on Monday. Here is the list of some big stocks moving higher in the previous session. 
Via Benzinga
Why Karuna Therapeutics Jumped Around 72%; Here Are 96 Biggest Movers From Yesterday
Gainers Helbiz, Inc. (NASDAQ: HLBZ) jumped 114.6% to close at $1.61 on Monday after climbing over 27% on Friday. 
Via Benzinga
< Previous 1 2
...
13 14 15 16 17 18 19 20 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.